about
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an ini...
Read More
5.05
0.11
(2.23%)
96,370.9
XNAS Volume
XNAS 06 Aug, 2026 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cingulate Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..